Latest News and Press Releases

PharmAla adds Matthew Azrieli to Advisory Team

PharmAla releases its Q1 financial statements

PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire

PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement

PharmAla announces private placement financing

MAPS’ “Music is the Bridge” blends artist playlists & free psychedelic education, inspiring exploration and connection. Visit MAPS.org/music-is-the-bridge

World’s leading psychedelic conference kicks off with workshops from leaders in science, medicine, therapy, policy, Indigenous medicine, and societyUpcoming deadline: speaker submissions, initial...

PharmAla reaches agreement in principle to trade with a clinical trial to trade its LaNeo MDMA for a data license to the trial outcomes.

PharmAla to supply Yale University with MDMA for clinical trial

PharmAla contracted to sell MDMA to Mt. Sinai Hospital, NY. Terminates Contract with CCrest Labs.